Medical Oncology

, 32:48 | Cite as

Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer

  • Ali Akbar Samadani
  • Haleh Akhavan-NiakiEmail author
Review Article


Gastric cancer may appear by frequent genetic or epigenetic changes in oncogenes, tumor suppressor or DNA mismatch repair genes. Molecular studies show the possibility of involvement of certain cancer pathways in gastric cancer. In this respect, DNA methylation is one of the most important epigenetic alterations in gastric cancer and identifying the signaling mechanism and also methylation of some genes that are involved in gastric cancer can help to improve treatment strategies. Relatively, there are many reported methylation alteration of genes in stem cells in all kinds of tumors with some of these genes having a key role in tumor development. Correspondingly, KLF5, CDX1/2, WNT1 and FEM1A are considerable genes in gastric cancer, although many researches and studies have illustrated that sonic hedgehog and expression of its signaling cascade proteins are related in gastric cancer. Relatively, modification in these genes causes many eclectic cancers such as rhabdomyosarcoma and diverse kinds of digestive system tumor development. Conspicuously, these master genes have a noticeable role in stem cell’s growth regulation as well as other kinds of cancer such as breast cancer and leukemia. Hence, we concluded that research and studies on methylation and expression of these genes and also the investigation of molecular signaling in gastric cancer can acquire impressive conclusions in order to control and treat this common place and serious problem.


Sonic hedgehog (SHH) DNA methylation Gastric cancer 


  1. 1.
    Wan J, et al. Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation. Biores Open Access. 2014;3(2):53–9.PubMedCentralCrossRefPubMedGoogle Scholar
  2. 2.
    Akhavan-Niaki H, Samadani AA. Molecular insight in gastric cancer induction: an overview of cancer stemness genes. Cell Biochem Biophys. 2014;68(3):463–73.CrossRefPubMedGoogle Scholar
  3. 3.
    Garcia-Gonzalez MA, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am J Gastroenterol. 2007;102(9):1878–92.CrossRefPubMedGoogle Scholar
  4. 4.
    Forbes SA, et al. The catalogue of somatic mutations in cancer (COSMIC). Curr Protoc Hum Genet. 2008; Chapter 10: p. Unit 10 11.Google Scholar
  5. 5.
    Yoshikawa A, et al. Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer. 1998;1(2):134–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Han ME, Oh SO. Gastric stem cells and gastric cancer stem cells. Anat Cell Biol. 2013;46(1):8–18.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Chen SY, et al. An overview of concepts for cancer stem cells. Cell Transplant. 2011;20(1):113–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Akhavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem Biophys. 2013;67(2):501–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang YJ, et al. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA. Clin Cancer Res. 2007;13(8):2378–84.CrossRefPubMedGoogle Scholar
  10. 10.
    Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010;11(3):204–20.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Ramirez JL, et al. 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: the Spanish Lung Cancer Group. J Clin Oncol. 2005;23(36):9105–12.CrossRefPubMedGoogle Scholar
  12. 12.
    Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet. 2013;14(3):204–20.CrossRefPubMedGoogle Scholar
  13. 13.
    Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer. 2003;3(4):253–66.CrossRefPubMedGoogle Scholar
  14. 14.
    Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature. 2001;414(6861):277–83.CrossRefPubMedGoogle Scholar
  15. 15.
    Jackson JP, et al. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature. 2002;416(6880):556–60.CrossRefPubMedGoogle Scholar
  16. 16.
    Costello JF, Plass C. Methylation matters. J Med Genet. 2001;38(5):285–303.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Wong TS, et al. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR. Eur J Cancer. 2003;39(13):1881–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Soon MS, et al. Expression of Kruppel-like factor 5 in gastric cancer and its clinical correlation in Taiwan. Virchows Arch. 2011;459(2):161–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Tsukamoto T, et al. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol. 2004;130(3):135–45.CrossRefPubMedGoogle Scholar
  20. 20.
    Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349(21):2042–54.CrossRefPubMedGoogle Scholar
  21. 21.
    Noto JM, et al. Helicobacter pylori promotes the expression of Kruppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo. PLoS ONE. 2013;8(1):e54344.PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Ogino S, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58(1):90–6.PubMedCentralCrossRefPubMedGoogle Scholar
  23. 23.
    Wang C, et al. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer. Oncology. 2003;64(3):259–65.CrossRefPubMedGoogle Scholar
  24. 24.
    Edkins S, et al. Recurrent KRAS codon 146 mutations in human colorectal cancer. Cancer Biol Ther. 2006;5(8):928–32.PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Bureau C, et al. Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis. Curr Genomics. 2009;10(5):353–60.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Fujii Y, et al. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc Natl Acad Sci USA. 2012;109(50):20584–9.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Almeida R, et al. Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol. 2003;199(1):36–40.CrossRefPubMedGoogle Scholar
  28. 28.
    Eda A, et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol. 2002;37(2):94–100.CrossRefPubMedGoogle Scholar
  29. 29.
    Bonner CA, Loftus SK, Wasmuth JJ. Isolation, characterization, and precise physical localization of human CDX1, a caudal-type homeobox gene. Genomics. 1995;28(2):206–11.CrossRefPubMedGoogle Scholar
  30. 30.
    Mizoshita T, et al. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol. 2004;130:29–36.CrossRefPubMedGoogle Scholar
  31. 31.
    Bai Y, et al. Distinct expression of CDX2 and GATA4/5, development-related genes, in human gastric cancer cell lines. Mol Carcinog. 2000;28(3):184–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Lee CS, et al. SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm. Development. 2000;127(1):109–18.PubMedGoogle Scholar
  33. 33.
    Tanaka K, et al. The evolutionarily conserved porcupine gene family is involved in the processing of the Wnt family. Eur J Biochem. 2000;267(13):4300–11.CrossRefPubMedGoogle Scholar
  34. 34.
    Tice DA, et al. Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem. 2002;277(16):14329–35.CrossRefPubMedGoogle Scholar
  35. 35.
    Griffiths EA, et al. Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas. Br J Cancer. 2007;96(1):95–103.PubMedCentralCrossRefPubMedGoogle Scholar
  36. 36.
    Ventura-Holman T, et al. The Fem1a gene is downregulated in Rhabdomyosarcoma. Tumour Biol. 2005;26(6):294–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Goodarzi MO, et al. FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome. Hum Reprod. 2008;23(12):2842–9.PubMedCentralCrossRefPubMedGoogle Scholar
  38. 38.
    Maher JF, et al. FEM1A is a candidate gene for polycystic ovary syndrome. Gynecol Endocrinol. 2005;21(6):330–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol. 2006;12(2):192–8.PubMedCentralPubMedGoogle Scholar
  40. 40.
    Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10(8):789–99.CrossRefPubMedGoogle Scholar
  41. 41.
    Ruiz i Altaba A. Gli proteins encode context-dependent positive and negative functions: implications for development and disease. Development. 1999;126(14):3205–16.PubMedGoogle Scholar
  42. 42.
    Schetter AJ, et al. Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res. 2009;15(18):5878–87.PubMedCentralCrossRefPubMedGoogle Scholar
  43. 43.
    Pruitt K, et al. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet. 2006;2(3):e40.PubMedCentralCrossRefPubMedGoogle Scholar
  44. 44.
    Tsang DP, Cheng AS. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2. J Gastroenterol Hepatol. 2011;26(1):19–27.CrossRefPubMedGoogle Scholar
  45. 45.
    Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168–74.CrossRefPubMedGoogle Scholar
  46. 46.
    Lu X, et al. Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors. Biochimie. 2008;90(5):697–704.CrossRefPubMedGoogle Scholar
  47. 47.
    Gendron FP, et al. The CDX2 transcription factor regulates furin expression during intestinal epithelial cell differentiation. Am J Physiol Gastrointest Liver Physiol. 2006;290(2):G310–8.CrossRefPubMedGoogle Scholar
  48. 48.
    Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther. 2004;3(7):593–601.CrossRefPubMedGoogle Scholar
  49. 49.
    Silberg DG, et al. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 2002;122(3):689–96.CrossRefPubMedGoogle Scholar
  50. 50.
    Almeida R, et al. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J Pathol. 2005;207(4):396–401.CrossRefPubMedGoogle Scholar
  51. 51.
    Zhang H, Xue Y. Wnt pathway is involved in advanced gastric carcinoma. Hepatogastroenterology. 2008;55(84):1126–30.PubMedGoogle Scholar
  52. 52.
    Meireles SI, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res. 2004;64(4):1255–65.CrossRefPubMedGoogle Scholar
  53. 53.
    Fujiwara K, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res. 2005;11(3):1219–25.PubMedGoogle Scholar
  54. 54.
    Samadani AA, Nikbakhsh N, Fattahi S, Pourbagher R, Aghajanpour Mir SM, Mousavi Kani N, Abedian Z, Akhavan-Niaki, H. RNA extraction from animal and human’s cancerous tissues: does tissue matter? Int J Mol Cell Med. 2015;4(1):54–9.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Cellular and Molecular Biology Research CenterBabol University of Medical SciencesBabolIran

Personalised recommendations